This Week’s Biotech Highlights
Lots of biotech and pharma deal activity is ongoing in Canada and around the world, including Roche’s debt offering to fund its Genentech bid and an unsolicited offer by JLL Partners for Patheon, which was founded in Canada.
New regulations are on the way for organic food in Canada, where cloned animals will be excluded; and for genetic information in the U.S., where the EEOC started hearings to implement Title II of the Genetic Information Nondiscrimination Act.
Regulatory optimism from GTC Biotherapeutics, which started a collaboration with New Zealand’s AgResearch for animal-produced biosimilars; but pessimism from . . . [more]
